Article
Governing Human Germline Editing Through Patent Law
30 Aug 2021
Abstract excerpt
This Viewpoint discusses ethical considerations and use of patents for human germline editing in the context of a recent World Health Organization report and release of several auxiliary documents exploring international governance tools for human genome engineering.
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
